JP2006526658A5 - - Google Patents

Download PDF

Info

Publication number
JP2006526658A5
JP2006526658A5 JP2006515186A JP2006515186A JP2006526658A5 JP 2006526658 A5 JP2006526658 A5 JP 2006526658A5 JP 2006515186 A JP2006515186 A JP 2006515186A JP 2006515186 A JP2006515186 A JP 2006515186A JP 2006526658 A5 JP2006526658 A5 JP 2006526658A5
Authority
JP
Japan
Prior art keywords
sucrose
complex
lyophilized
liposome
lyophilized formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006515186A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006526658A (ja
JP4987474B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/017695 external-priority patent/WO2005000271A1/en
Publication of JP2006526658A publication Critical patent/JP2006526658A/ja
Publication of JP2006526658A5 publication Critical patent/JP2006526658A5/ja
Application granted granted Critical
Publication of JP4987474B2 publication Critical patent/JP4987474B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

JP2006515186A 2003-06-04 2004-06-04 リポソーム複合体の安定性および使用期限を改良するための方法 Expired - Fee Related JP4987474B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47550003P 2003-06-04 2003-06-04
US60/475,500 2003-06-04
PCT/US2004/017695 WO2005000271A1 (en) 2003-06-04 2004-06-04 Method for improving stability and shelf-life of liposome complexes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011281918A Division JP2012121885A (ja) 2003-06-04 2011-12-22 リポソーム複合体の安定性および使用期限を改良するための方法

Publications (3)

Publication Number Publication Date
JP2006526658A JP2006526658A (ja) 2006-11-24
JP2006526658A5 true JP2006526658A5 (zh) 2007-08-02
JP4987474B2 JP4987474B2 (ja) 2012-07-25

Family

ID=33551542

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006515186A Expired - Fee Related JP4987474B2 (ja) 2003-06-04 2004-06-04 リポソーム複合体の安定性および使用期限を改良するための方法
JP2011281918A Pending JP2012121885A (ja) 2003-06-04 2011-12-22 リポソーム複合体の安定性および使用期限を改良するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011281918A Pending JP2012121885A (ja) 2003-06-04 2011-12-22 リポソーム複合体の安定性および使用期限を改良するための方法

Country Status (14)

Country Link
US (1) US20050002998A1 (zh)
EP (1) EP1633327B1 (zh)
JP (2) JP4987474B2 (zh)
CN (2) CN1798545B (zh)
AT (1) ATE476964T1 (zh)
AU (1) AU2004251680B2 (zh)
CA (1) CA2528411C (zh)
DE (1) DE602004028610D1 (zh)
DK (1) DK1633327T3 (zh)
ES (1) ES2350485T3 (zh)
HK (2) HK1086202A1 (zh)
PL (1) PL1633327T3 (zh)
PT (1) PT1633327E (zh)
WO (1) WO2005000271A1 (zh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617514B2 (en) 1999-02-22 2013-12-31 Georgetown University Tumor-targeted nanodelivery systems to improve early MRI detection of cancer
JP4571514B2 (ja) * 2005-01-21 2010-10-27 ポーラ化成工業株式会社 ベシクル系外用組成物
WO2006119121A2 (en) * 2005-04-29 2006-11-09 University Of Louisville Research Foundation, Inc. Cell-surface decoration with active agents
KR20080064169A (ko) * 2005-10-20 2008-07-08 조지타운 유니버시티 암의 초기 ｍｒｉ 검출을 개선하기 위한 종양-표적화나노전달 시스템
JP2009537526A (ja) * 2006-05-15 2009-10-29 ジョージタウン・ユニバーシティ 治療もしくは診断剤の全身投与のための抗体もしくは抗体断片標的化免疫リポソームの製造およびその使用
JPWO2007132873A1 (ja) * 2006-05-17 2009-09-24 義之 小山 核酸、オリゴ核酸、又はその誘導体導入用の凍結乾燥体
WO2008094971A2 (en) 2007-01-30 2008-08-07 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Bioerodible wraps and uses therefor
CN101801344A (zh) 2007-07-09 2010-08-11 乔治敦大学 关于使用阳离子脂质体介导的核酸递送产生免疫应答的方法
CN101485629B (zh) * 2008-01-16 2013-01-23 沈阳药科大学 一种给药系统及其制备方法
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
US9402812B2 (en) 2009-09-23 2016-08-02 Indu JAVERI Methods for the preparation of liposomes
AU2010315417B2 (en) 2009-10-28 2016-12-15 Neograft Technologies, Inc. Bioerodible wraps and uses therefor
CA2785989A1 (en) 2009-12-31 2011-07-07 Neograft Technologies, Inc. Graft devices and methods of fabrication
US9801853B2 (en) 2010-04-06 2017-10-31 Fred Hutchinson Cancer Research Center Methods for identifying and using inhibitors of casein kinase 1 epsilon isoform for inhibiting the growth and/or proliferation of MYC-driven tumor cells
US9445874B2 (en) 2010-07-19 2016-09-20 Neograft Technologies, Inc. Graft devices and methods of use
US9579224B2 (en) 2011-07-25 2017-02-28 Neograft Technologies, Inc. Vessel remodeling methods and devices for use in a graft device
US20140120157A1 (en) 2012-09-19 2014-05-01 Georgetown University Targeted liposomes
CA2806896C (en) 2012-09-19 2021-06-15 Georgetown University Targeted liposomes prepared by ethanol injection
EP2968598B1 (en) 2013-03-14 2020-05-27 Georgetown University Treatment for exposure to nerve agent
WO2015077602A1 (en) 2013-11-22 2015-05-28 Fred Hutchinson Cancer Research Center Methods for identifying therapeutic targets and treating and monitoring cancers
EP3227434A4 (en) * 2014-12-03 2018-07-11 Capricor, Inc. Processes for producing exosomes in reduced oxygen culture conditions
PL3324932T3 (pl) * 2015-07-22 2021-07-05 Nitto Denko Corporation Kompozycje i sposoby dla liofiliozwanych postaci nanocząstek
WO2017192863A1 (en) 2016-05-04 2017-11-09 L.E.A.F. Holdings Group Llc Targeted liposomal gemcitabine compositions and methods thereof
EP3493790A4 (en) * 2016-08-02 2020-03-25 Curirx Inc. LIPOSOME PREPARATION METHODS
BR112020007470A2 (pt) * 2017-10-20 2020-10-27 Biontech Rna Pharmaceuticals Gmbh métodos para produzir um colóide de lipossoma, para preparar partículas, para a fabricação de fluxo contínuo, para preparar uma composição congelada e para preparar uma composição aquosa, colóide de lipossoma, composições, composição congelada e composição aquosa

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
JPH01106829A (ja) * 1987-10-21 1989-04-24 Tosoh Corp スーパーオキサイドジスムターゼ保持リポソーム製剤の凍結乾燥法
WO1993020802A1 (en) * 1992-04-09 1993-10-28 Northwestern University Acoustically reflective liposomes and methods to make and use the same
US5753262A (en) * 1995-06-07 1998-05-19 Aronex Pharmaceuticals, Inc. Cationic lipid acid salt of 3beta N- (N', N'-dimethylaminoethane) - carbamoyl!cholestrol and halogenated solvent-free preliposomal lyophilate thereof
US5811406A (en) 1995-06-07 1998-09-22 Regents Of The University Of California Dry powder formulations of polynucleotide complexes
AU707734B2 (en) * 1995-06-07 1999-07-15 Regents Of The University Of California, The Stabilization of polynucleotide complexes
CA2308584C (en) * 1997-11-19 2011-07-19 Georgetown University Targeted liposome gene delivery
CA2362550C (en) * 1999-02-22 2010-05-11 Georgetown University Antibody fragment-targeted immunoliposomes for systemic gene delivery
JP2001002592A (ja) * 1999-06-18 2001-01-09 Dai Ichi Seiyaku Co Ltd 遺伝子導入用組成物
JP2001316297A (ja) * 2000-02-23 2001-11-13 Kaken Pharmaceut Co Ltd 遺伝子包埋リポソーム製剤及びその製法
US6372250B1 (en) * 2000-04-25 2002-04-16 The Regents Of The University Of California Non-invasive gene targeting to the brain
AU2003293543A1 (en) * 2002-12-13 2004-07-09 Abgenix, Inc. System and method for stabilizing antibodies with histidine

Similar Documents

Publication Publication Date Title
JP4987474B2 (ja) リポソーム複合体の安定性および使用期限を改良するための方法
JP2006526658A5 (zh)
JP6027592B2 (ja) 核酸−リポポリマー組成物
US9827331B2 (en) Nucleic acid-lipopolymer compositions
JP4551464B2 (ja) インビボ送達に有効な、脂質−核酸複合体の安定な製剤の調製
Algarni et al. In vivo delivery of plasmid DNA by lipid nanoparticles: the influence of ionizable cationic lipids on organ-selective gene expression
US20060269542A1 (en) Immunoliposome composition for targeting to a HER2 cell receptor
EP1001750B1 (en) Stable particulate complexes with neutral or negative globale charge of lamellar structure
JP2000516630A (ja) 全身への送達を増加させる新規のリポソーム複合体
JP2004525138A (ja) 治療剤の改良された細胞内送達のためのリポソーム組成物
WO1996034109A1 (en) Single-vial formulations of dna/lipid complexes
JP7333635B2 (ja) ｍＲＮＡを細胞に送達するための改善した脂質－ペプチドナノ複合体製剤
CN115087437A (zh) 脂质组合物及其用于将治疗活性剂递送至内皮的用途
Liu et al. Design and self-assembly of albumin nanoclusters as a dynamic-covalent targeting co-delivery and stimuli-responsive controlled release platform
US20240033374A1 (en) Nano-structural Protein Degradation Tool, Use, and Preparation Method thereof, and Lipid-based Protein Degradation Tool, Use, and Preparation Method thereof
JP2020521004A (ja) ｃ（ＲＧＤ−ＡＣＰ−Ｋ）修飾血中滞留型リポソーム
Mohammed Saeid Physiochemical stability and mass spectrometric analysis of gemini surfactant-based lipoplexes